BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23228891)

  • 1. Psychometric analysis in support of shortening the Scale for the Assessment of Negative Symptoms.
    Levine SZ; Leucht S
    Eur Neuropsychopharmacol; 2013 Sep; 23(9):1051-6. PubMed ID: 23228891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing negative symptoms in schizophrenia: Validity of the clinical assessment interview for negative symptoms in Singapore.
    Rekhi G; Ang MS; Yuen CKY; Ng WY; Lee J
    Schizophr Res; 2019 Apr; 206():177-182. PubMed ID: 30558979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying clinically meaningful symptom response cut-off values on the SANS in predominant negative symptoms.
    Levine SZ; Leucht S
    Schizophr Res; 2013 Apr; 145(1-3):125-7. PubMed ID: 23394742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multisite investigation of the reliability of the Scale for the Assessment of Negative Symptoms.
    Mueser KT; Sayers SL; Schooler NR; Mance RM; Haas GL
    Am J Psychiatry; 1994 Oct; 151(10):1453-62. PubMed ID: 7916540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new rating scale for negative symptoms: the Motor-Affective-Social Scale.
    Trémeau F; Goggin M; Antonius D; Czobor P; Hill V; Citrome L
    Psychiatry Res; 2008 Sep; 160(3):346-55. PubMed ID: 18722021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Depressive symptoms and negative symptoms during schizophrenia].
    Dollfus S; Langlois S; Assouly-Besse F; Petit M
    Encephale; 1995 Jun; 21 Spec No 3():23-7. PubMed ID: 7628337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does catatonia influence the phenomenology of childhood onset schizophrenia beyond motor symptoms?
    Bonnot O; Tanguy ML; Consoli A; Cornic F; Graindorge C; Laurent C; Tordjman S; Cohen D
    Psychiatry Res; 2008 Apr; 158(3):356-62. PubMed ID: 18272234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Core factors of schizophrenia structure based on PANSS and SAPS/SANS results. Discerning and head-to-head comparisson of PANSS and SASPS/SANS validity].
    Masiak M; Loza B
    Psychiatr Pol; 2004; 38(5):795-808. PubMed ID: 15523927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical predictors of discrepancy between self-ratings and examiner ratings for negative symptoms.
    Selten JP; Wiersma D; van den Bosch RJ
    Compr Psychiatry; 2000; 41(3):191-6. PubMed ID: 10834628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying a system of predominant negative symptoms: Network analysis of three randomized clinical trials.
    Levine SZ; Leucht S
    Schizophr Res; 2016 Dec; 178(1-3):17-22. PubMed ID: 27617414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Validation of the Temporal Experience of Pleasure Scale (TEPS) in a French-speaking environment].
    Favrod J; Ernst F; Giuliani F; Bonsack C
    Encephale; 2009 Jun; 35(3):241-8. PubMed ID: 19540410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative symptoms in schizophrenia: a confirmatory factor analysis of competing models.
    Peralta V; Cuesta MJ
    Am J Psychiatry; 1995 Oct; 152(10):1450-7. PubMed ID: 7573583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Brief Negative Symptom Scale and its association with functioning.
    Ang MS; Rekhi G; Lee J
    Schizophr Res; 2019 Jun; 208():97-104. PubMed ID: 30987926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment response heterogeneity in the predominant negative symptoms of schizophrenia: analysis of amisulpride vs placebo in three clinical trials.
    Levine SZ; Leucht S
    Schizophr Res; 2014 Jun; 156(1):107-14. PubMed ID: 24794879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations to improve the positive and negative syndrome scale (PANSS) based on item response theory.
    Levine SZ; Rabinowitz J; Rizopoulos D
    Psychiatry Res; 2011 Aug; 188(3):446-52. PubMed ID: 21463902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The factor structure of clinical symptoms in mixed and manic episodes prior to and after antipsychotic treatment.
    Harvey PD; Endicott JM; Loebel AD
    Bipolar Disord; 2008 Dec; 10(8):900-6. PubMed ID: 19594505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Negative schizophrenic symptoms and their detection].
    Kukla F; Gold R
    Fortschr Neurol Psychiatr; 1991 Feb; 59(2):60-6. PubMed ID: 2026379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the Brief Psychiatric Rating Scale and the Scale for the Assessment of Negative Symptoms: a study of their correlation and redundancy.
    Czobor P; Bitter I; Volavka J
    Psychiatry Res; 1991 Feb; 36(2):129-39. PubMed ID: 2017528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of negative symptoms and depression in schizophrenia: revision of the SANS and how it relates to the PANSS and CDSS.
    Rabany L; Weiser M; Werbeloff N; Levkovitz Y
    Schizophr Res; 2011 Mar; 126(1-3):226-30. PubMed ID: 21115328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative symptoms in schizophrenia: their evolution during an acute phase.
    Dollfus S; Petit M
    Schizophr Res; 1995 Oct; 17(2):187-94. PubMed ID: 8562493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.